Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26280
Abstract: Newly diagnosed advanced‐stage ovarian cancer patients are treated with neoadjuvant chemotherapy, primary or intermediate cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study is to evaluate the optimal timing of cytoreduction plus… read more here.
Keywords: plus hipec; cancer patients; ovarian cancer; advanced ovarian ... See more keywords
The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC)
Sign Up to like & getrecommendations! Published in 2022 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-022-06466-8
Abstract: Epithelial ovarian cancer is usually diagnosed in the advanced stages. To choose the best therapeutic approach, an accurate preoperative assessment of the tumour extent is crucial. This study aimed to determine whether the peritoneal cancer… read more here.
Keywords: cancer; tumour extent; pci; advanced ovarian ... See more keywords
Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-018-1371-7
Abstract: BackgroundThe management of refractory ascites in advanced ovarian cancer (AOC) is vital for patients with abdominal distention, respiratory distress, and anorexia due to massive ascites with cancer peritonitis. We analyzed the benefits of concentrated ascites… read more here.
Keywords: cart; massive ascites; management; cancer ... See more keywords
When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of minimally invasive gynecology"
DOI: 10.1016/j.jmig.2018.09.765
Abstract: STUDY OBJECTIVE To compare outcomes of advanced ovarian cancer patients who had minimally invasive surgery (MIS) with outcomes of advanced ovarian cancer patients who had laparotomy for interval cytoreduction after neoadjuvant chemotherapy (NACT). DESIGN Retrospective… read more here.
Keywords: surgery; minimally invasive; ovarian cancer; cancer ... See more keywords
HIPEC in patients with primary advanced ovarian cancer: Is there a role? A systematic review of short- and long-term outcomes.
Sign Up to like & getrecommendations! Published in 2018 at "Surgical oncology"
DOI: 10.1016/j.suronc.2018.05.006
Abstract: A systematic review of the studies where HIPEC combined with cytoreductive surgery was used in patients with primary advanced ovarian cancer was performed to understand is there a role for this treatment modality not only… read more here.
Keywords: primary advanced; systematic review; ovarian cancer; patients primary ... See more keywords
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.09.001
Abstract: OBJECTIVES Surgical resection of enlarged cardiophrenic lymph nodes (CPLNs) in primary treatment of advanced ovarian cancer has not been widely studied. We report on a cohort of patients undergoing CPLN resection during primary cytoreductive surgery… read more here.
Keywords: cardiophrenic lymph; feasibility safety; ovarian cancer; advanced ovarian ... See more keywords
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2018.10.006
Abstract: OBJECTIVES Our objective was to determine the safety and efficacy of acute normovolemic hemodilution (ANH) to reduce the requirement for allogenic red blood cell (RBC) transfusions in patients undergoing primary cytoreduction for advanced ovarian cancer.… read more here.
Keywords: patients undergoing; blood; ovarian cancer; undergoing primary ... See more keywords
Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach).
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2020.11.011
Abstract: OBJECTIVE To evaluate the feasibility of bat-shaped en-bloc total peritonectomy and total hysterectomy-salpingo-oophorectomy with or without rectosigmoid resection as a novel approach in advanced ovarian cancer surgery. METHODS Advanced ovarian cancer patients with widespread peritoneal… read more here.
Keywords: surgery; total peritonectomy; bat; rectosigmoid resection ... See more keywords
Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2021.01.024
Abstract: OBJECTIVE To determine if laparoscopy is a cost-effective way to assess disease resectability in patients with newly diagnosed advanced ovarian cancer. METHODS A cost-effectiveness analysis from a health care payer perspective was performed comparing two… read more here.
Keywords: cost; laparoscopy; ovarian cancer; advanced ovarian ... See more keywords
Visceral segmental serosectomy during debulking surgery for advanced ovarian and fallopian tubal cancer
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic Oncology"
DOI: 10.1016/s0090-8258(21)01279-8
Abstract: Objectives: To evaluate the effect and safety of conservatively ablative operation as an alternative to low anterior resection (LAR) on postoperative outcomes and survival in patients with advanced ovarian cancer. Methods: We collected data of… read more here.
Keywords: surgery; colon; rectosigmoid colon; cancer ... See more keywords
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment
Sign Up to like & getrecommendations! Published in 2020 at "Nature Communications"
DOI: 10.1038/s41467-020-17383-2
Abstract: Advanced ovarian cancer usually spreads to the omentum. However, the omental cell-derived molecular determinants modulating its progression have not been thoroughly characterized. Here, we show that circulating ITLN1 has prognostic significance in patients with advanced… read more here.
Keywords: cell derived; ovarian cancer; cancer cells; cancer ... See more keywords